RZLT Biotechnology Penny Stock Reports in the next day LONGRZLT is a biotechnology company which has products in clinical development. Many are aware that means rigorous clinical trials before an FDA approval and a product line that generates earnings. Stock price is more about growth and potential more than anything else. That
said the chart looks good and I sense there is momentum heading into earnings in the next day
so this is a buy for me. I can see that price broke above a recent supply/resistance zone. This
penny stock likely cannot be shorted so there is no selling pressure to be exerted until present
longs have found their target. This can add to the momentum without the drag of that short selling. A penny here and a penny there it all adds up over time especially with compounding in active trading with penny stocks that have great range.
FGEN
FGEN A Biotechnology Penny running to earnings LONGFGEN has been uptrending for two weeks. In November's earnings it beat on revenue and
burned less cash than projected. Another earnings report is impending. On the 30 minute
chart, price has pumped 250%. The volume is okay but is not showing a rise and the price
volume trend is flat. This is an unusual pattern. The mass index indicator shows hints of
getting into the threshold and trigger zones. The dual TF RSI shows both low and high TF lines
in the 60s. I am inclined to watch this, the price rise without corresponding volume increases
seems to run against Wychoff theory. I will put it on a watch list. As a speculative penny
stock with no earnings I will leave it alone until I see increased volume and volatility at
earnings. Could there be some manipulation hidden behind the chart?
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!